Abstract
We have previously shown that among normal leukocytes, CD56+ and CD8+ cells express relatively high levels of P-glycoprotein (P-gp), a transmembrane efflux pump. While the physiologic significance of P-gp expression in leukocytes is unknown, the relatively high levels of P-gp in CD56+ and CD8+ cells suggest that P-gp may function in cell-mediated cytolysis. To explore this possibility we examined the effect of four inhibitors of P-gp efflux [(R)-verapamil (R-ver), (S) -verapamil (S-ver), cyclosporine A (CsA), and PSC833 (PSC)] on both the inhibition of natural killer cell (NK) function and on P-gp efflux. NK function was assayed by measuring the lysis of51Cr-labeled K562 target cells in the presence and absence of inhibitors. All four P-gp efflux inhibitors inhibited NK-mediated cytolysis in a dose-dependent manner. The stereoisomers of verapamil were more potent inhibitors of cell-mediated cytolysis than the cyclosporines CsA and PSC. In contrast, CsA and PSC were more potent as inhibitors of P-gp-mediated rhodamine 123 dye efflux than the verapamil isomers. Both CsA and PSC maximally inhibited P-gp efflux at 3μM, but only minimally inhibited cell-mediated cytolysis. The verapamil compounds demonstrated closer correlation between efflux inhibition and inhibition of NK-mediated cytolysis. The data support a role for P-gp in NK-mediated cytolysis; however, these studies also suggest that the NK cytolytic process is multifaceted and that inhibition of the P-gp-mediated efflux mechanism only partially abrogates this process.
Similar content being viewed by others
References
Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152–162, 1976
Kessel D, Botterill V, Wodinsky I: Uptake and retention of daunomycin by mouse leukemic cells as factors in drag response. Cancer Res 28:938–941, 1968
Kessel D, Beck WT, Kukuruga D, Schulz V: Characterization of multidrug resistance by fluorescent dyes. Cancer Res 51:4665–4670, 1991
Raymond M, Gros P, Whiteway M, Thomas DY: Functional complementation of yeast ste6 by mammalian multidrug resistance mdr gene. Science 256:232–234, 1992
Salmon SE, Grogan TM, Miller T, Scheper R, Dalton WS: Prediction of doxorubicin resistancein vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 81:696–701, 1989
Chan HSL, Thorner PS, Haddad G, Ling V: Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689–704, 1990
Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC: Immunohistochemical localization in normal tissues of different epitopes in a multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 37:159–164, 1989
Cordon-Cardo C, O'Brien P, Boccia J, Casals D, Bertino JR, Melamed MR: Expression of the multidrag resistance gene product (p-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38:1277–1287, 1990
Chaudhary PM, Mechetner EB, Roninson IB: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735–2739, 1992
Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M: Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2729–2734, 1992
Klimecki WT, Futscher BW, Grogan TM, Dalton WS: P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451–2458, 1994
Chong AS, Markham PN, Gebel HM, Bines SD, Coon JS: Diverse multidrug-resistance modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother 36:133–139, 1993
Weir MR, Peppler R, Gomolka D, Handwerger BS: Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine. Transplantation 51:851–857, 1991
Markham PN, Coon JS, Chong AS, Gebel HM: Natural killer cell cytotoxicity and the multidrug resistance gene. Transplant Proc 25:96–97, 1993
Weir MR, Peppler R, Gomolka D, Handwerger BS: Evidence that the antiproliferative effect of verapamil on afferent and efferent immune responses is independent of calcium channel inhibition. Transplantation 54:681–685, 1992
Boesch D, Gaveriaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P, Loor F:In vivo circumvention of P-glycoproteinmediated resistance of tumor cells with SDZ PSC 833. Cancer Res 51:4226–4233, 1991
Hamada H, Tsuruo T: Functional role for the 170–180 kDa glycoprotein specific to drug resistant tumor cells as treated by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785–7789, 1986
Gupta S, Gollapudi S: P-glycoprotein (MDR 1 gene product) in cells of the immune system: Its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J Clin Immunol 13:289–301, 1993
Gupta S, Kim CH, Tsurao T, Gollapudi S: Preferential expression and activity of multidrug resistance gene-1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: A role in cytotoxic effector function. J Clin Immunol 12:451–458, 1992
DiPadova FE: Pharmacology of cyclosporine (Sandimmune) V. Pharmacological effects on immune function:In vitro studies. Pharmacol Rev 41:373–394, 1989
Foxwell BM, Mackie A, Ling V, Ryffel B: Identification of the multidrug-resistance-related P-glycoprotein as a cyclosporinebinding protein. Mol Pharmacol 36:543–546, 1989
Herberman RB, Reynolds CW, Ortaldo J: Mechanisms of cytotoxicity by natural killer cells. Annu Rev Immunol 4:651–667, 1986
Woods G, Lund LA, Naik M, Ling V, Ochi A: Resistance of multidrug-resistant lines to natural killer like cell-mediated cytotoxicity. FASEB J 2:2791–2796, 1988
Yanovich S, Hall RE, Weinert C: Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line. Cancer Res 46:4511–4515, 1986
Seheper RJ, Dalton WS, Grogan TM, Schlosser A, Bellamy WT, Taylor CW, Scuderi P, Spier C: Altered expression of P-glycoprotein and cellular adhesion molecules on human multidrug resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity. Int J Cancer 48:562–567, 1991
Kagl D, Ledermann B, Burkl K, Seller P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31–37, 1994
Criado M, Lindstrom JM, Anderson CG, Dennert G: Cytotoxic granules from killer cells: Specificity of granules and insertion of channels of defined size into target membranes. J Immunol 135:4245–4251, 1985
Schmid DS, Tite JP, Ruddle NH: DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. Proc Natl Acad Sci USA 83:1881–1885, 1986
Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 76:2421–2438, 1990
Kuchler K, Thorner J: Secretion of peptides and proteins lacking hydrophobic signal sequences: The role of adenosine triphosphatedriven membrane translocators. Endocrine Rev 13:499–514, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klimecki, W.T., Taylor, C.W. & Dalton, W.S. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine a analogs. J Clin Immunol 15, 152–158 (1995). https://doi.org/10.1007/BF01543107
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01543107